Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit
- Thursday, December 1, 2022, 7:10
- PR Newswire
- Add a comment
NEWARK, Calif., Dec. 1, 2022 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat presentation and host one-on-one meetings…
About the Author
admin has written 20652 stories on this site.